Gene · 1585
Papers3,065
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,065
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| No Evidence of QTc Interval Prolongation With Baxdrostat Treatment: Concentration-QTc Modeling Assessment. | Pharmacol Res Perspect | 2025 | 41084132 | PubTator, text mining | PubMed |
| Efficacy and safety of lorundrostat in patients with uncontrolled or resistant hypertension: A systematic review and meta-analysis with trial sequential analysis. | Vascul Pharmacol | 2025 | 41067555 | PubTator, text mining | PubMed |
| Redox partner adrenodoxin induces substrate binding to steroidogenic cytochrome P450 11B2 and 11A1 by promoting a conformational change. | J Biol Chem | 2025 | 41062063 | PubTator, text mining | PubMed |
| Efficacy and Safety of Lorundrostat in Patients With Uncontrolled and Treatment-Resistant Hypertension: A Systematic Review and Meta-Analysis. | Cureus | 2025 | 41054668 | PubTator, text mining | PubMed |
| Therapeutic approaches in the management of chronic kidney disease: the past, the present, and the future. | Minerva Med | 2025 | 41051293 | PubTator, text mining | PubMed |
| Aldosterone in Chronic Kidney Disease. | Biomedicines | 2025 | 41007644 | PubTator, text mining | PubMed |
| Efficacy and Safety of Lorundrostat in Uncontrolled Hypertension: A Systematic Review and Meta-Analysis. | J Clin Hypertens (Greenwich) | 2025 | 40991241 | PubTator, text mining | PubMed |
| Endocrine effects of long-term calcineurin inhibitor use in solid organ transplant recipients. | Eur J Endocrinol | 2025 | 40966721 | PubTator, text mining | PubMed |
| Glucocorticoid Remediable Aldosteronism in a Family with a Strong History of Cerebral Aneurysms and Hypertension. | Prague Med Rep | 2025 | 40966436 | PubTator, text mining | PubMed |
| tsRNA-25172 inhibits aldosterone secretion in aldosterone-producing adenomas. | Endocr Connect | 2025 | 40956684 | PubTator, text mining | PubMed |
| [The relationship between surgical outcomes and KCNJ5 mutations and pathological classification in patients with unilateral primary aldosteronism]. | Zhonghua Xin Xue Guan Bing Za Zhi | 2025 | 40953986 | PubTator, text mining | PubMed |
| Aldosterone synthase inhibition: a novel bullet to fight cardiovascular-kidney-metabolic syndrome. | J Mol Endocrinol | 2025 | 40911485 | PubTator, text mining | PubMed |
| The Emerging Role of Aldosterone Synthase Inhibitors in Overcoming Renin-Angiotensin-Aldosterone System Therapy Limitations: A Narrative Review. | Card Fail Rev | 2025 | 40901557 | PubTator, text mining | PubMed |
| Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension. | N Engl J Med | 2025 | 40888730 | PubTator, text mining | PubMed |
| Aldosterone Synthase Inhibition for Hypertension. | N Engl J Med | 2025 | 40888729 | PubTator, text mining | PubMed |
| Is CXCR4-targeted 68Ga-pentixafor PET/CT a reliable AVS-free modality for surgical decision-making and prognostic prediction in primary aldosteronism with bilateral adrenal lesions? | EJNMMI Res | 2025 | 40875090 | PubTator, text mining | PubMed |
| Aldosterone and Cardiovascular Risk Across the Lifespan. | Metabolites | 2025 | 40863169 | PubTator, text mining | PubMed |
| Baxdrostat for uncontrolled and resistant hypertension: rationale and design of the Phase 3 clinical trials BaxHTN, BaxAsia, and Bax24. | Hypertens Res | 2025 | 40850955 | PubTator, text mining | PubMed |
| Different Polymorphisms of the Renin-Angiotensin-Aldosterone System Genes are Associated with Poorer Blood Pressure Control in Hypertensive Older Adults. | High Blood Press Cardiovasc Prev | 2025 | 40830690 | PubTator, text mining | PubMed |
| Establishment and evaluation of a patient-derived organoids-based xenograft model of primary aldosteronism using [18F]AlF-NOTA-pentixather PET/CT: bridging preclinical and clinical imaging. | J Transl Med | 2025 | 40826430 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1585/papers?page=9